NCT07264023Not yet recruiting
Correlation Between Nutritional Status of Childhood Neurological Tumors and Quality of Life
A Prospective, Observational, Multicenter Longitudinal Cohort Study on the Correlation Between Nutritional Status and Quality of Life in Children With Neuro-oncological Tumors During the Peri-radiotherapy Period.
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
Maintaining good nutritional status during treatment for children with cancer is crucial for many outcomes, such as overall survival rate, tolerance to treatment, susceptibility to infection, and quality of life. Neurotumors in children account for the highest proportion among solid tumors in children. Previous studies have clearly shown that neurotumors in children have different nutritional characteristics from hematological tumors and other solid tumors in children. Our retrospective data found that there was a significant correlation between the BMI Z values of children with neurotumors before and during radiotherapy and the frequency of adverse events. The occurrence of adverse events has a negative impact on the quality of life of child patients. Therefore, we plan to conduct a prospective, observational, multi-center longitudinal cohort study to evaluate the dynamic changes in nutritional status during the peri-radiotherapy period, explore the correlation between nutritional status and quality of life in children with neurotumors before and after radiotherapy, and establish a nutritional management plan and nutritional risk early warning model suitable for Chinese children with neurotumors.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 93 (estimated)
- First submitted
- 23 Nov 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 31 May 2027
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Diseases
- Childhood cancers
- NCT number
- NCT07264023
What you commit to
- Study type: Observational
- Planned participants: 93
- From 15 Dec 2025 to the primary completion date, 31 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Accompanied by other serious complications;
- The researcher judged that it was not suitable to participate in this study.
Who the study is looking for
- The patient and the legal guardian have agreed to sign the informed consent form;
- Age ≥ 5 years old and ≤ 18 years old;
- The pathological or clinical diagnosis is a neurological tumor;
- Patient has indications for radiotherapy;
- The expected survival time is over 6 months.
Age in the registry: 5 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.